English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 2, 2026

ATRA report alleges coordinated use of manufactured science in mass tort litigation
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Biopharma mergers and acquisitions reach $46.8 billion in first quarter of 2026
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Alliance for Consumers report examines trial law firms’ political donations and public contracting relationships
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Ohio State Health & Discovery discusses cognitive behavioral therapy for weight loss
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Lung cancer survivors and advocates to meet Congress for research and care funding
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Validated mechanisms and strong data emphasized in longevity investing, experts say
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Sanofi announces partnership with Kali Therapeutics in $1 billion immunology deal
+ Pharmaceuticals
Patient Daily | Mar 30, 2026

Pfizer expresses confidence in Lyme vaccine after mixed Phase 3 trial results

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 10, 2026

Definium and Compass Pathways advance psychedelic drug candidates toward key milestones